Suppr超能文献

医院病房抗生素处方与艰难梭菌感染的风险。

Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection.

机构信息

Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Department of Anthropology and School of the Environment, McGill University, Montreal, Quebec, Canada.

出版信息

JAMA Intern Med. 2015 Apr;175(4):626-33. doi: 10.1001/jamainternmed.2014.8273.

Abstract

IMPORTANCE

Only a portion of hospital-acquired Clostridium difficile infections can be traced back to source patients identified as having symptomatic disease. Antibiotic exposure is the main risk factor for C difficile infection for individual patients and is also associated with increased asymptomatic shedding. Contact with patients taking antibiotics within the same hospital ward may be a transmission risk factor for C difficile infection, but this hypothesis has never been tested.

OBJECTIVES

To obtain a complete portrait of inpatient risk that incorporates innate patient risk factors and transmission risk factors measured at the hospital ward level and to investigate ward-level rates of antibiotic use and C difficile infection risk.

DESIGN, SETTING, AND PATIENTS: A 46-month (June 1, 2010, through March 31, 2014) retrospective cohort study of inpatients 18 years or older in a large, acute care teaching hospital composed of 16 wards, including 5 intensive care units and 11 non-intensive care unit wards.

EXPOSURES

Patient-level risk factors (eg, age, comorbidities, hospitalization history, antibiotic exposure) and ward-level risk factors (eg, antibiotic therapy per 100 patient-days, hand hygiene adherence, mean patient age) were identified from hospital databases.

MAIN OUTCOMES AND MEASURES

Incidence of hospital-acquired C difficile infection as identified prospectively by hospital infection prevention and control staff.

RESULTS

A total of 255 of 34 298 patients developed C difficile (incidence rate, 5.95 per 10,000 patient-days; 95% CI, 5.26-6.73). Ward-level antibiotic exposure varied from 21.7 to 56.4 days of therapy per 100 patient-days. Each 10% increase in ward-level antibiotic exposure was associated with a 2.1 per 10,000 (P < .001) increase in C difficile incidence. The association between C difficile incidence and ward antibiotic exposure was the same among patients with and without recent antibiotic exposure, and C difficile risk persisted after multilevel, multivariate adjustment for differences in patient-risk factors among wards (relative risk, 1.34 per 10% increase in days of therapy; 95% CI, 1.16-1.57).

CONCLUSIONS AND RELEVANCE

Among hospital inpatients, ward-level antibiotic prescribing is associated with a statistically significant and clinically relevant increase in C difficile risk that persists after adjustment for differences in patient-level antibiotic use and other patient- and ward-level risk factors. These data strongly support the use of antibiotic stewardship as a means of preventing C difficile infection.

摘要

重要性

只有一部分医院获得性艰难梭菌感染可以追溯到被确定为有症状疾病的源患者。抗生素暴露是个体患者发生艰难梭菌感染的主要危险因素,也与无症状脱落增加有关。与同一医院病房内使用抗生素的患者接触可能是艰难梭菌感染的传播危险因素,但这一假设从未得到过验证。

目的

获得完整的住院风险图,其中包括内在的患者危险因素和在医院病房层面测量的传播危险因素,并调查病房层面的抗生素使用和艰难梭菌感染风险。

设计、地点和患者:这是一项回顾性队列研究,在一家大型急性护理教学医院的 16 个病房(包括 5 个重症监护病房和 11 个非重症监护病房)中,对 18 岁或以上的住院患者进行了 46 个月(2010 年 6 月 1 日至 2014 年 3 月 31 日)的研究。

暴露因素

从医院数据库中确定了患者层面的危险因素(如年龄、合并症、住院史、抗生素暴露)和病房层面的危险因素(如每 100 名患者-天的抗生素治疗、手卫生依从性、平均患者年龄)。

主要结果和测量指标

前瞻性由医院感染预防和控制人员确定的医院获得性艰难梭菌感染的发生率。

结果

共有 255 名 34298 名患者发生艰难梭菌感染(发生率为每 10000 患者-天 5.95 例;95%CI,5.26-6.73)。病房级别的抗生素暴露从每天 21.7 到 56.4 天不等。病房级别的抗生素暴露每增加 10%,艰难梭菌的发病率就会增加 2.1 例/10000 例(P<0.001)。在有和没有近期抗生素暴露的患者中,艰难梭菌发病率与病房抗生素暴露之间的关联是相同的,并且在对病房间患者危险因素进行多层次、多变量调整后,艰难梭菌风险仍然存在(相对风险,每增加 10%的治疗天数增加 1.34;95%CI,1.16-1.57)。

结论和相关性

在住院患者中,病房级别的抗生素处方与艰难梭菌感染风险的显著统计学和临床相关增加相关,并且在调整患者水平的抗生素使用和其他患者和病房水平的危险因素后仍然存在。这些数据有力地支持将抗生素管理作为预防艰难梭菌感染的一种手段。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验